Neurocysticercosis: a major cause of neurological disease worldwide.
暂无分享,去创建一个
[1] K. O'Hoy,et al. Vaccination against ovine cysticercosis using a defined recombinant antigen , 1989, Nature.
[2] J. Joubert,et al. Neurocysticercosis in 578 black epileptic patients. , 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[3] G. Román,et al. Therapy for neurocysticercosis: a reappraisal. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] A. Flisser,et al. Taenia solium ocular cysticercosis: findings in 30 cases. , 1992, Annals of ophthalmology.
[5] A. Flisser,et al. Dipstick dot ELISA for the detection of Taenia coproantigens in humans , 1993, Parasitology.
[6] A. Flisser,et al. Epidemiological investigation of Taenia solium taeniasis and cysticercosis in a rural village of Michoacan state, Mexico. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[7] J. A. Brand,et al. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). , 1989, The Journal of infectious diseases.
[8] A. White,et al. Effects of serum from neurocysticercosis patients on the structure and viability of Taenia solium oncospheres. , 1993, The Journal of parasitology.
[9] C. Filley,et al. Neurocysticercosis in the United States: 35 cases and a review. , 1987, Reviews of infectious diseases.
[10] A. Flisser,et al. Neurocysticercosis in an Orthodox Jewish community in New York City. , 1992, The New England journal of medicine.
[11] V. Rajshekhar. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy , 1991, Acta neurologica Scandinavica.
[12] Z. Jiang,et al. Nationwide survey of human parasite in China. , 1994, The Southeast Asian journal of tropical medicine and public health.
[13] T. Crawford,et al. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. , 1988, Pediatrics.
[14] R. Gilman,et al. The marketing of cysticercotic pigs in the Sierra of Peru. The Cysticercosis Working Group in Peru. , 1993, Bulletin of the World Health Organization.
[15] T. Govezensky,et al. Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. , 1992, Archives of neurology.
[16] Relationship Between Epilepsy and Tropical Diseases , 1994 .
[17] S. Waterman,et al. Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County. , 1992, The American journal of tropical medicine and hygiene.
[18] H. R. Martinez,et al. Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases , 1995, Journal of the Neurological Sciences.
[19] R. J. Otto,et al. MR imaging of neurocysticercosis. , 1989, AJR. American journal of roentgenology.
[20] A de Aluja,et al. The histopathology of porcine cysticercosis. , 1988, Veterinary parasitology.
[21] O. D. Del Brutto. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patientswith neurocysticercosis , 1994, Neurology.
[22] C. Suquet,et al. Parasite defense mechanisms for evasion of host attack; a review. , 1987, Veterinary parasitology.
[23] O. D. Brutto. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patientswith neurocysticercosis , 1994 .
[24] F. Rubio-Donnadieu,et al. Praziquantel in the treatment of neurocysticercosis , 1985, Neurology.
[25] G. Mitchell,et al. Stage‐specific immunity to Taenia taeniaeformis infection in mice. A histological study of the course of infection in mice vaccinated with either oncosphere or metacestode antigens , 1990, Parasite immunology.
[26] D. McManus,et al. An IgG (Fcγ,)-binding protein of Taenia crassiceps (Cestoda) exhibits sequence homology and antigenic similarity with schistosome paramyosin , 1993, Parasitology.
[27] A. White,et al. Extraparenchymal neurocysticercosis: report of five cases and review of management. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] P. Preux,et al. Headache and Cysticercosis in Ecuador, South America , 1995, Headache.
[29] O. D. Brutto. Cysticercosis and cerebrovascular disease: a review. , 1992 .
[30] R. Bryan,et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. , 1991, The Journal of infectious diseases.
[31] R. Gilman,et al. Epidemiology of taeniasis and cysticercosis in a Peruvian village. The Cysticercosis Working Group in Peru. , 1992, American journal of epidemiology.
[32] E. Love,et al. Surveillance and Control Programs for Cestode Diseases , 1989 .
[33] J. Sotelo,et al. A new shunt for hydrocephalus that relies on CSF production rather than on ventricular pressure: initial clinical experiences. , 1995, Surgical neurology.
[34] J. Goding,et al. Studies on immune responses to larval cestodes in mice. Increased susceptibility of certain mouse strains and hypothymic mice to Taenia taeniaeformis and analysis of passive transfer of resistance with serum. , 1977, The Australian journal of experimental biology and medical science.
[35] A. White,et al. Asymptomatic neurocysticercosis in a patient with AIDS and cryptococcal meningitis. , 1995, American Journal of Medicine.
[36] S. Geerts. Cysticercosis in Africa. , 1995, Parasitology today.
[37] D. Mendonça,et al. Spectrum of epilepsy in neurocysticercosis: a long‐term follow‐up of 143 patients , 1995, Acta neurologica Scandinavica.
[38] McCormick Gf. Cysticercosis--review of 230 patients. , 1985 .
[39] A. Jena,et al. MRI (magnetic resonance imaging) spectrum of epilepsy. , 1994, Journal of the Indian Medical Association.
[40] C. Suquet,et al. Isolation and partial characterization of a Taenia taeniaeformis metacestode proteinase inhibitor. , 1984, International journal for parasitology.
[41] M. Cruz,et al. Potential eradicability of taeniasis and cysticercosis. , 1993, Bulletin of the Pan American Health Organization.
[42] H. Dixon,et al. Cysticercosis , 1962, Neurology.
[43] F. Dabis,et al. Epidemiological study of neuro-cysticercosis in northern Togo (West Africa). , 1989, Acta Leidensia.
[44] A. Flisser. Neurocysticercosis in Mexico. , 1988, Parasitology today.
[45] M. Cruz,et al. Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. , 1989, Bulletin of the World Health Organization.
[46] A. Mirsky,et al. Neurocysticercosis and performance on neuropsychologic tests: a family study in Ecuador. , 1995, The American journal of tropical medicine and hygiene.
[47] D. D. Heath,et al. Taenia ovis recombinant vaccine – ‘quo vadit’ , 1995, Parasitology.
[48] G. Locke,et al. Cerebral cysticercosis: documentation of natural history with CT. , 1989, Radiology.
[49] B. Estañol,et al. Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy. , 1983, Neurosurgery.
[50] M. Cruz,et al. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[51] Xiao Zx,et al. [Cysticercosis of the central nervous system--a clinical study of 1,400 cases]. , 1988 .
[52] M. T. Medina,et al. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. , 1990, Archives of internal medicine.
[53] J. Sotelo,et al. Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. , 1987, Journal of neurosurgery.
[54] R. Norman,et al. Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel. , 1983, Annals of internal medicine.
[55] J. Seidel. Diagnostic Pathology of Parasitic Infection with Clinical Correlation , 1991 .
[56] G. McCormick. Cysticercosis--review of 230 patients. , 1985, Bulletin of clinical neurosciences.
[57] W. Shandera,et al. Neurocysticercosis in Houston, Texas: A Report of 112 Cases , 1994, Medicine.
[58] M. Behari,et al. Albendazole in neurocysticercosis. , 1995, The National medical journal of India.
[59] R. Gilman,et al. Factors associated with Taenia solium cysticercosis: analysis of nine hundred forty-six Peruvian neurologic patients. Cysticercosis Working Group in Peru (CWG). , 1995, The American journal of tropical medicine and hygiene.
[60] R. Kuhn,et al. Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and downregulation of Th1-associated phenomena , 1996, Parasitology.
[61] A. Carpio,et al. A Proposal for Classification of Neurocysticercosis , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[62] W. Hauser,et al. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? , 1997, Archives of internal medicine.
[63] A. Flisser,et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[64] A. Flisser,et al. Cysticercosis: present state of knowledge and perspectives. , 1982 .
[65] C. Cantú,et al. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. , 1996, Archives of neurology.
[66] C. Shoemaker,et al. Paramyosin inhibits complement C1. , 1992, Journal of immunology.
[67] F. Rubio-Donnadieu,et al. Therapy of parenchymal brain cysticercosis with praziquantel. , 1984, The New England journal of medicine.
[68] J. Sotelo,et al. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. , 1988, Archives of neurology.
[69] S. Shulman,et al. Neurocysticercosis among children in Chicago. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[70] D. Bikin,et al. Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. , 1994, The Journal of infectious diseases.
[71] M. Hay,et al. Seizures and neurocysticercosis in black men. , 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[72] A. White,et al. Host-parasite interactions in Taenia solium cysticercosis. , 1992, Infectious agents and disease.
[73] P. Bittencourt,et al. High-dose praziquantel for neurocysticercosis: efficacy and tolerability. , 1990, European neurology.
[74] G. Trenholme. Discrepancies Between Cerebral Computed Tomography and Western Blot in the Diagnosis of Neurocysticercosis , 1994 .
[75] J. Sotelo,et al. The course of seizures after treatment for cerebral cysticercosis. , 1992, The New England journal of medicine.
[76] A. Hightower,et al. Seroprevalence of cysticercosis in an Orthodox Jewish community. , 1995, The American journal of tropical medicine and hygiene.
[77] H. García,et al. Diagnosis of cysticercosis in endemic regions , 1991, The Lancet.
[78] A. White,et al. Taenia solium cysticercosis: host-parasite interactions and the immune response. , 1997, Chemical immunology.
[79] M L Apuzzo,et al. Surgical considerations in treatment of intraventricular cysticercosis. An analysis of 45 cases. , 1984, Journal of neurosurgery.
[80] C. Zee,et al. MRI of Intraventricular Cysticercosis: Surgical Implications , 1993, Journal of computer assisted tomography.
[81] V. Tsang,et al. Taenia solium cysticercosis: An under-recognized but serious publica health problem , 1995 .
[82] R. Rangel,et al. Cysticercotic encephalitis: a severe form in young females. , 1987, The American journal of tropical medicine and hygiene.